Clinical Trial Update: p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management

View source ↗

Summary

This completed clinical trial examines biomarker staining (p16 and Ki-67) and natural killer cells in CIN-II management within cervical cancer care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Parc de Salut Mar | Conditions: Cervical Cancer | Status: COMPLETED